drugset / Trial / NCT03700658
A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this study is to evaluate the local tolerability associated with the SC administration of TV-46046, and inform next steps of the TV-46046 development program.
Timeline
- Start
- 2019-01-15
- Primary completion
- 2020-10-02
- Completion
- 2020-10-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Depo-subQ 104 | Unknown | 104 mg | Subcutaneous |
| Subject | medroxyprogesterone acetate | Other / unclassified | 60 mg | Subcutaneous |
| Subject | medroxyprogesterone acetate | Other / unclassified | 120 mg | Subcutaneous |
Indications
No indication recorded.